e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Should all adult cystic fibrosis patients with repeated nontuberculous mycobacteria cultures receive specific treatment? A 10-year case–control study
Albrecht Christiane, Ringshausen Felix, Ott Sebastian, Wagner Dirk, Rademacher Jessica, Schneider Michael, Welte Tobias, Pletz Mathias W.
Source:
Eur Respir J 2016; 47:1575-1577
Journal Issue:
May
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Albrecht Christiane, Ringshausen Felix, Ott Sebastian, Wagner Dirk, Rademacher Jessica, Schneider Michael, Welte Tobias, Pletz Mathias W.. Should all adult cystic fibrosis patients with repeated nontuberculous mycobacteria cultures receive specific treatment? A 10-year case–control study. Eur Respir J 2016; 47:1575-1577
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Salivary SLPI and disease severity in bronchiectasis
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Related content which might interest you:
Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases
Source: Eur Respir J 2001; 18: Suppl. 33, 443s
Year: 2001
Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003
A randomized study of bronchoscopic blockade of the affected part of a lung as a part the complex treatment of patients with drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012
Non-tuberculous mycobacterium infection in adult patients: a 10-year single-centre experience
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
A study of patients with pulmonary tuberculosis and confirmed coexistence of nontuberculous mycobacteria during treatment: Does the use of the additional acid-fast bacilli sputum test lead to shorter hospitalization?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients
Source: Eur Respir J 2002; 20: Suppl. 38, 547s
Year: 2002
Frequency of mycobacteriosis among the patients with positive cultures of nontuberculous mycobacteria (NTM) – 5 year study
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004
A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Incidence and prevalence of non tuberculous mycobacteria [NTM] in adult CF population: A large adult CF centre experience
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients
Source: Eur Respir J 2001; 18: 306-315
Year: 2001
Prospective study of nontuberculous mycobacteria (NTM) isolates in children with cystic fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002
Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study
Source: ERJ Open Res, 6 (4) 00061-2020; 10.1183/23120541.00061-2020
Year: 2020
Routine liver function test monitoring of patients treated for active M.TB infection does not influence management: A real-world retrospective study
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018
Mortality outcomes in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a real world study
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021
Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses
Source: Eur Respir J 2001; 18: Suppl. 33, 473s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept